PACIRA BIOSCIENCES, INC. (PCRX) Operating cash flow 2016–2025
PACIRA BIOSCIENCES, INC. (PCRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$152.0MFY2025 · since FY2016: $33.5M → $152.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $152.0M | -19.7% |
| FY2024 | $189.4M | +22.5% |
| FY2023 | $154.6M | +6.5% |
| FY2022 | $145.3M | +15.6% |
| FY2021 | $125.7M | +63.2% |
| FY2020 | $77.0M | +9.2% |
| FY2019 | $70.5M | +44.3% |
| FY2018 | $48.9M | +174.8% |
| FY2017 | $17.8M | -46.8% |
| FY2016 | $33.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PCRX financial trends
PCRX RevenuePCRX Net incomePCRX Net marginPCRX Gross profitPCRX Gross marginPCRX Operating incomePCRX Operating marginPCRX Free cash flowPCRX Capital expendituresPCRX Return on equityPCRX Stock buybacksPCRX Dividends paidPCRX Total assetsPCRX Total liabilitiesPCRX Shareholders’ equityPCRX overview →